Showing results (1-10 of 59) with videos related to
Sort By:
Pageof 6
Current Opinion in Rheumatology|November 1, 2002
Cytokine directed therapy in scleroderma: rationale, current status, and the futureRobert W Simms, Joseph H KornArthritis and Rheumatism|July 29, 2006
Durometry for the assessment of skin disease in systemic sclerosisEugene Y Kissin, Aileen M Schiller, Rondi B Gelbard, et al.Arthritis & Rheumatology (Hoboken, N.J.)|June 21, 2020
Expert Perspectives On Clinical Challenges: Expert Perspectives: Challenges in SclerodermaRobert W SimmsCurrent Rheumatology Reports|March 14, 2002
Apoptosis and myofibroblasts in the pathogenesis of systemic sclerosisEugene Kissin, Joseph H KornJournal of Scleroderma and Related Disorders|April 7, 2022
Geographic disparity in systemic sclerosis mortality in the United States: 1999-2017Alicia Rodriguez-Pla, Robert W SimmsRheumatic Diseases Clinics of North America|July 5, 2003
Fibrosis in sclerodermaEugene Y Kissin, Joseph H KornJournal of Intensive Care Medicine|June 15, 2010
Care of patients with scleroderma in the intensive care settingHarrison W Farber, Robert W Simms, Robert LafyatisArthritis and Rheumatism|June 4, 2005
Increased expression of type I collagen induced by microfibril-associated glycoprotein 2: novel mechanistic insights into the molecular basis of dermal fibrosis in sclerodermaRaphael Lemaire, Joseph H Korn, J Michael Shipley, et al.Matrix Biology : Journal of the International Society for Matrix Biology|March 8, 2006
Cartilage oligomeric matrix protein is overexpressed by scleroderma dermal fibroblastsGiuseppina Farina, Raphael Lemaire, Joseph H Korn, et al.Pageof 6